Saturday 17 October 2026
Export CC’s income statement to Excel — free account
The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue fell 1.49%, EPS grew 28.7%, free cash flow grew 128.0% and total debt fell 6.47%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
12.66
0.25
−1.94%
Follow CC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 4 | 3 |
+8 more TTM periods Free account |
| (318.32%) | (103.02%) | (93.80%) | (70.49%) | ||
| (4.15%) | (5.59%) | (5.18%) | (4.50%) | ||
ROIC |
(2.22%) | (1.50%) | (1.08%) | 0.24% | |
Return on Tangible Assets |
(7.13%) | (9.41%) | (8.79%) | (7.65%) | |
Average Days of Receivables |
57.11 | 47.59 | 42.67 | 59.23 | |
Free Cash Flow per Share |
1.44 | 1.02 | 0.34 | (0.05) | |
Free Cash Flow |
218.00 | 154.00 | 51.00 | (8.00) | |
Capital Expenditures |
(179.00) | (178.00) | (213.00) | (273.00) | |
| Other line items | |||||
Cash ROIC |
4.85% | 3.13% | 1.01% | (0.16%) | |
Accounts Receivable Turnover |
6.21 | 7.20 | 8.02 | 6.15 | |
Accounts Payable Turnover |
5.01 | 5.21 | 4.65 | 4.59 | |
Inventory Turnover |
3.26 | 3.20 | 3.24 | 3.23 | |
Average Days of Payables |
69.64 | 65.79 | 70.98 | 78.30 | |
Days of Inventory on Hand |
107.92 | 113.42 | 116.73 | 117.03 | |
Tax Rate |
4.87 | 0.37 | 0.39 | 0.70 | |
Research and Development Expense of Revenue |
1.83% | 1.84% | 1.86% | 1.83% | |
Selling, General and Administrative Expense of Revenue |
14.97% | 14.14% | 13.76% | 14.15% | |
Share Based Compensation of Revenue |
0.40% | 0.40% | 0.36% | 0.34% | |
Interest Coverage |
(0.41) | (0.33) | (0.24) | 0.06 | |
Operating CF/Net income |
(1.31) | (0.81) | (0.68) | (0.78) | |
Depreciation/Fixed assets |
0.11 | 0.11 | 0.11 | 0.11 | |
Capex/Depreciation |
(0.54) | (0.52) | (0.61) | (0.79) | |
Revenue per Share |
38.33 | 38.61 | 38.66 | 38.82 | |
Operating CF per Share |
2.63 | 2.20 | 1.76 | 1.76 | |
Capex per Share |
(1.18) | (1.18) | (1.42) | (1.82) | |
Capex to Sales |
0.03 | 0.03 | 0.04 | 0.05 |
Columns are period end dates